Cargando…
Trypsin-protease activated receptor-2 signaling contributes to pancreatic cancer pain
Pain treatment is a critical aspect of pancreatic cancer patient clinical care. This study investigated the role of trypsin-protease activated receptor-2 (PAR-2) in pancreatic cancer pain. Pancreatic tissue samples were collected from pancreatic cancer (n=22) and control patients (n=22). Immunofluor...
Autores principales: | Zhu, Jiao, Miao, Xue-Rong, Tao, Kun-Ming, Zhu, Hai, Liu, Zhi-Yun, Yu, Da-Wei, Chen, Qian-Bo, Qiu, Hai-Bo, Lu, Zhi-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617466/ https://www.ncbi.nlm.nih.gov/pubmed/28977906 http://dx.doi.org/10.18632/oncotarget.18696 |
Ejemplares similares
-
Replacement of Trypsin by Proteases for Medical Applications
por: Matinfar, Alireza, et al.
Publicado: (2022) -
Proteomics Using Protease Alternatives to Trypsin
Benefits from Sequential Digestion with Trypsin
por: Dau, Therese, et al.
Publicado: (2020) -
N-glycosylation in the protease domain of trypsin-like serine proteases mediates calnexin-assisted protein folding
por: Wang, Hao, et al.
Publicado: (2018) -
Contribution of purified soybean trypsin inhibitor and exogenous protease to endogenous amino acid losses and mineral digestibility
por: Aderibigbe, A.S., et al.
Publicado: (2021) -
Role of trypsin and protease-activated receptor-2 in ovarian cancer
por: Kim, Kyu Kwang, et al.
Publicado: (2020)